Cleared Special

COMBOMAP PRESSURE AND FLOW SYSTEM (K041134) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Special 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2004
Decision
33d
Days
Class 2
Risk

K041134 is an FDA 510(k) clearance for the COMBOMAP PRESSURE AND FLOW SYSTEM. Classified as Catheter, Ultrasound, Intravascular (product code OBJ), Class II - Special Controls.

Submitted by Volcano Therapeutics, Inc. (Rancho Cordova,, US). The FDA issued a Cleared decision on June 2, 2004 after a review of 33 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1200 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Volcano Therapeutics, Inc. devices

Submission Details

510(k) Number K041134 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 30, 2004
Decision Date June 02, 2004
Days to Decision 33 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
92d faster than avg
Panel avg: 125d · This submission: 33d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code OBJ Catheter, Ultrasound, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
Definition For Intracardiac And Intraluminal Visualization Of Cardiovascular Anatomy And Physiology.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - OBJ Catheter, Ultrasound, Intravascular

All 43
Devices cleared under the same product code (OBJ) and FDA review panel - the closest regulatory comparables to K041134.
ACUNAV DIAGNOSTIC ULTRASOUND CATHETER 8F AND 10F
K071234 · Siemens Medical Solutions USA, Inc. · Jun 2007
ILAB ULTRASOUND IMAGING SYSTEM
K051679 · Boston Scientific Corp · Jul 2005
ACUSON ACUNAV 8F ULTRASOUND CATHETER
K042593 · Siemens Medical Solutions USA, Inc. · Oct 2004
ACUNAV 90/10 DIAGNOSTIC ULTRASOUND CATHETER
K033650 · Siemens Medical Solutions USA, Inc. · Feb 2004